Scientists have reported promising long-term results from a study that combines a personalized mRNA vaccine with a leading immunotherapy drug to help stop melanoma from returning. The research, led by investigators at NYU Langone Health and its Perlmutter Cancer Center, suggests that the treatment may significantly improve survival and reduce the risk of cancer spreading. […]

The post New mRNA Vaccine Could Lower Skin Cancer Death Risk appeared first on Knowridge Science Report.